Inspire Medical Systems, Inc.
INSPNYSEHealthcare● Active
$42.00
+$0.81(+1.97%)
Market Cap$1.2B
P/E Ratio—
52W High$147.03
52W Low$38.91
Inspire Medical Systems, Inc. (INSP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · INSP · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.91B | $0.80B | $0.62B | $0.41B | $0.23B |
| Cost of Revenue | $0.13B | $0.12B | $0.10B | $0.07B | $0.03B |
| Gross Profit | $0.78B | $0.68B | $0.53B | $0.34B | $0.20B |
| Gross Margin %(computed) | 85.39% | 84.68% | 84.54% | 83.79% | 85.74% |
| Operating Expenses | |||||
| R&D Expenses | $0.10B | $0.11B | $0.12B | $0.07B | $0.04B |
| G&A Expenses | $0.00B | $0.43B | $0.35B | $0.25B | $0.15B |
| Total Operating Expenses | $0.73B | $0.64B | $0.57B | $0.39B | $0.24B |
| Operating Income | $0.05B | $0.04B | ($0.04B) | ($0.05B) | ($0.04B) |
| Operating Margin %(computed) | 5.59% | 4.49% | -6.45% | -11.67% | -17.07% |
| Interest Income | $0.02B | $0.02B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.07B | $0.06B | ($0.02B) | ($0.04B) | ($0.04B) |
| Income Tax Expense | ($0.08B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.15B | $0.05B | ($0.02B) | ($0.04B) | ($0.04B) |
| Net Margin %(computed) | 15.95% | 6.67% | -3.39% | -11.00% | -18.01% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $4.95 | $1.80 | $-0.72 | $-1.60 | $-1.54 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.06B | $0.07B | ($0.02B) | ($0.04B) | ($0.04B) |
| EBITDA Margin %(computed) | 7.12% | 8.10% | -2.73% | -9.99% | -16.55% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Inspire Medical Systems, Inc. data
About Inspire Medical Systems, Inc. (INSP) Income Statement
Inspire Medical Systems, Inc. (INSP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, INSP reported revenue of $0.91B, gross profit of $0.78B (gross margin 85.39%), and net income of $0.15B — a net profit margin of 15.95%.
Frequently asked questions
INSP · 4 questionsInspire Medical Systems, Inc. (INSP) reported revenue of $0.91B for 2025, up 13.6% year-over-year.
INSP revenueINSP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08